People: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

7.09USD
3:38pm EDT
Price Change (% chg)

$-0.13 (-1.81%)
Prev Close
$7.22
Open
$7.21
Day's High
$7.30
Day's Low
$7.03
Volume
1,683,329
Avg. Vol
6,469,446
52-wk High
$8.61
52-wk Low
$2.26

Search Stocks

Deshpande, Milind 

Brief Biography

Dr. Milind S. Deshpande, Ph.D., is President, Chief Executive Officer, Director of Achillion Pharmaceuticals Inc. Prior to joining Achillion in September 2001, Dr. Deshpande was Associate Director of Lead Discovery and Early Discovery Chemistry at the Pharmaceutical Research Institute at Bristol-Myers Squibb, a pharmaceutical company, from 1991 to 2001, where he managed the identification of new clinical candidates to treat infectious and neurological diseases. From 1988 to 1991, he held a faculty position at Boston University Medical School. Dr. Deshpande received his Ph.D. in Organic Chemistry from Ohio University, following his undergraduate education in India.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
584,476 -- 4,268,960 4,853,430

Options Compensation

  Quantity Market Value
Exercisable 485,000 --
Unexercisable -- --
Exercised 15,937 139,342.00
Name Fiscal Year Total

David Scheer

--

Milind Deshpande

4,853,430

Mary Kay Fenton

989,616

Gautam Shah

883,243

David Apelian

2,175,130

Joseph Truitt

886,617
As Of 30 Dec 2013
Search Stocks